Octagon Capital Advisors »

Gyre Therapeutics Incorporated shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.3M 954k 6.59

More positions owned by Octagon Capital Advisors

Dianthus Therapeutics (DNTH)
Definium Therapeutics Com Shs (DFTX)
Abivax Sa Sponsored Ads (ABVX)
Cogent Biosciences (COGT)
Alumis (ALMS)
Arrivent Biopharma (AVBP)
Taysha Gene Therapies Com Shs (TSHA)
Bioage Labs (BIOA)
Mirum Pharmaceuticals (MIRM)
Kymera Therapeutics (KYMR)
Aktis Oncology (AKTS)
Xenon Pharmaceuticals (XENE)
Erasca Call Call Option
Palisade Bio (PALI)
Ocular Therapeutix (OCUL)

View all positions for Octagon Capital Advisors

Top funds holding Gyre Therapeutics Incorporated

Sc China Holding
BlackRock
Octagon Capital Advisors
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
Sixth Street Partners Management Company
Northern Trust
SBI Securities
Vanguard Fiduciary Trust
Vanguard Portfolio Management
Goldman Sachs Group
Bank of New York Mellon
OTR - Nominee Name for The State Teachers Retirement Board of Ohio

View all funds holding Gyre Therapeutics Incorporated